Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada

Journal of Medical Virology

Volumn 83, Issue 6, 2011, Pages 1034-1041

  Coutlée, François ^a,b,c   Ratnam, Samuel ^c,d   Ramanakumar, Agnihotram V ^c   Insinga, Ralph R ^e   Bentley, James ^f   Escott, Nicholas ^g   Ghatage, Prafull ^h   Koushik, Anita ^b,c   Ferenczy, Alex ⁱ   Franco, Eduardo L ^c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Newfoundland and Labrador Public Health Laboratory   (Canada)

^e MERCK RESEARCH LABORATORIES   (United States)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g Regional Health Sciences Centre   (Canada)

^h TOM BAKER CANCER CENTRE   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

CIN; HPV genotyping; Human papillomavirus; Invasive cervical cancer; PCR

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CANCER GRADING; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CANADA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 79954599461     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22081     Document Type: Article

References (33)

1. Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC. 1998. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 178:1235-1244.
2. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, IBSCC Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 87:796-802.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
4. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10:321-322.
5. Burk RD, Chen Z, Van Doorslaer K. 2009. Human papillomaviruses: Genetic basis of carcinogenicity. Public Health Genomics 12:281-290.
6. Carreon JD, Sherman ME, Guillen D, Solomon D, Herrero R, Jeronimo J, Wacholder S, Rodriguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M. 2007. CIN2 is a much less reproducible and less valid diagnosis than CI N3: Results from a histological review of population-based cervical samples. Int J Gynecol Pathol 26:441-446.
7. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. 2010. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19:1675-1681.
8. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
9. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
10. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157-1164.
11. Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL. 2006. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24:S26-S34.
12. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay J, Schlagg P, Boyle S, Hankins C, Vézina D, Cote P, Macleod J, Voyer H, Forest P, Walmsley S, Franco EL. 2006. Enhanced detection and typing of human papillomavirus DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 44:1998-2006.
13. Coutlee F, Rouleau D, Ghattas G, Hankins C, Vezina S, Cote P, Macleod J, de Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E. 2007. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol 45:3821-3823.
14. Gohy L, Gorska I, de Pokomandy A, Rouleau D, Ghattas G, Allaire G, Cote P, Vézina D, Macleod J, Franco EL, Coutlee F. 2008. Genotyping of human papillomavirus in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acq Immun Def Syndr 49:32-39.
15. Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. 2007. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol 45:3245-3250.
16. Harper DM. 2009. Prevention of human papillomavirus infections and associated diseases by vaccination: A new hope for global public health. Public Health Genomics 12:319-330.
17. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807.
18. Ho GYF, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. 1998. HPV 16 and cigarette smoking as risk actors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78:281-285.
19. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. 2008. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 17:1611-1622.
20. Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha EH, Muñoz N, Paavonen J, Haupt RM. 2011. Incident cervical HPV infections in young women: Transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomed Prev 20:287-296.
21. Jeronimo J, Massad LS, Schiffman M. 2007. Visual appearance of the uterine cervix: Correlation with human papillomavirus detection and type. Am J Obstet Gynecol 197:47.
22. Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlee F, Franco EL. 2005. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Det Prev 29:307-316.
23. MacLehose RF, Harpster A, Lanier AP, Schiff MA, Koehler K, Murphy N, Becker TM. 1999. Risk factors for cervical intraepithelial neoplasm in Alaska Native women: A pilot study. Alaska Med 41:76-85.
24. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah K, Snidjers PJF, Meijer CJLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 348:518-527.
25. Munoz N, Bosch FX, Castellsague X, Diaz M, de-Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
26. Roberts CC, Tadesse AS, Sands J, Halvorsen T, Schofield TL, Dalen A, Skjeldestad FE, Jansen KU. 2006. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J Clin Virol 36:277-282.
27. Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE. 2009. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res 69:3262-3266.
28. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
29. The Atypical Squamous Cells of Undetermined Significance/Low Grade Squamous Lesions Triage Study (ALTS) Group. 2003. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188:1383-1392.
30. Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous-Elbaz A, Drouin P, Wheeler C, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, DiPaolo J, Gravitt P, Franco EL, Coutlée F. 2003. Herpes simplex virus type II (HSV-2) is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 188:129-134.
31. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
32. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. 2009. Human papillomavirus genotype distributions: Implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101:475-487.
33. Woodman CB, Collins S, Rollason TP, Winter H, Bailey A, Yates M, Young LS. 2003. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet 361:40-43.